[SLRX] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
12-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -89.75%
YoY- 0.38%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 1,243 1,133 1,039 875 165 105 163 287.90%
PBT -1,784 -2,084 -1,882 -2,630 -1,385 -2,230 -2,009 -7.61%
Tax 62 -286 1 -2 0 0 -51 -
NP -1,784 -2,084 -1,883 -2,628 -1,385 -2,230 -2,009 -7.61%
Tax Rate - - - - - - - -
Total Cost 3,028 3,217 2,922 3,503 1,549 2,335 2,172 24.82%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -143.51 -183.95 -181.27 -300.33 -840.76 -2,124.68 -1,232.52 -76.18%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -3.20 -5.46 -14.40 -18.22 -11.48 -77.16 -69.50 -87.17%
EPS Diluted -3.20 -5.46 -14.40 -18.22 -11.48 -77.16 -69.50 -87.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.